L'histoire derrière Technologies Kaster.

Founded in 2022, Kaster Technologies emerged from university research after our founder's deeply personal encounter with drug shortages. When Alex's older daughter was affected by medication shortages during a treatment, a routine pharmacy visit turned into weeks of anxious waiting and uncertainty. This situation sparked a pivotal question: why, in an age of technological advancement, were drug shortages still so common?

eye

While billions are being invested in new drug development and cutting-edge biotech facilities, a quieter challenge often goes unnoticed: the way daily drug manufacturing operations are coordinated. Even in the most advanced facilities, the complexity of aligning people, equipment and processes is still being managed through a patchwork of spreadsheets and manual decisions. This isn't a sign of poor management, it's the reality of heavily regulated industries built on legacy systems.

As a result, valuable capacity can remain hidden, and production delays can ripple through the supply chain, sometimes contributing to shortages. Many teams acknowledge scheduling as a persistent challenge, often saying it's "too complex or costly to fix". Traditional solutions have always been heavy, expensive and slow to deliver value, which is eactly why it was worth rethinking.

We saw what many looked past, a problem too complex, too messy, too accepted to fix. To make medicine more accessible, you have to start with how it's made, and give teams the tools to run production without chaos. From that moment, it was not just an academic question to answer, it became an industrial solution.

Like a cast on a fractured system, we bring structure where it’s missing, and stability where it matters most. Our technology doesn’t just improve how large-scale drug manufacturing is coordinated, it supports the backbone of pharmaceutical manufacturing, helping life-saving treatments reach patients, reliably.

Powering Resilient Medicine Supply Worldwide.

This is our vision.
We unite data, people, and processes into real-time decisions that keep medicines moving.

Comité consultatif

Andrei Uglar

Associé, Beta3Capital

Amanda Arciero

Cofondatrice et VP des opérations, Airudi Inc.

Caroline Chevrier

Entrepreneur en série

Louis-Martin Rousseau, Ph.D.

Conseiller scientifique fondateur

Carrières

Nous sommes toujours à la recherche de personnes passionnées et talentueuses qui souhaitent avoir un impact concret. Si vous êtes prêt à contribuer à l’équipe et à nous aider à réduire les pénuries de médicaments, nous aimerions avoir votre avis.

Candidature spontanée